In the second installment of his experience taking Addium during a 30-day trial period, BTR staffer Zach Schepis talks about whether or not the experimental pills provided him with boosted cognition. He also reflects on the withdrawal experienced from caffeine addiction.
BTR writer Zach Schepis decides to try an experimental new brain-enhancing drug called Addium in the first part of an ongoing series. Very little research is available on the supplement; only first-hand experience will tell.